SCHEMBL20109304

SCHEMBL20109304

CC(C)N1[C@H](c2ccccc2)[C@@H](c2ccccc2)N(C(C)C)P1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.34
ALDH1A1 P00352 2/20 0.34
NPSR1 Q6W5P4 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
CHRNA7 P36544 1/20 0.32
TP53 P04637 2/20 0.32
MDM2 Q00987 2/20 0.32
HRH3 Q9Y5N1 3/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
KCNH2 Q12809 1/20 0.31
KDM1A O60341 1/20 0.31
TSHR P16473 2/20 0.31
KIF11 P52732 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19367680 0.72 ATM (0.37) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL4047153 0.72 ATM (0.39) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL4055784 0.72 ATM (0.39) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL4047147 0.72 ATM (0.39) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL999798 0.72 ATM (0.39) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL19374549 0.68 ATM (0.33) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL19367683 0.67 SMN1; SMN2 (0.36) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL20109310 0.66 FAAH (0.31)
SCHEMBL30561555 0.64 ATM (0.48) ATMALDH1A1NPSR1SMN1; SMN2MEN1
SCHEMBL8517882 0.64 ATM (0.48) ATMALDH1A1NPSR1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 ATM 3008/4885ALDH1A1 4621/4885NPSR1 1082/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 ATM 3008/4885ALDH1A1 4621/4885NPSR1 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.